West Branch Capital LLC Decreases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

West Branch Capital LLC reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 26.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,632 shares of the pharmacy operator’s stock after selling 600 shares during the quarter. West Branch Capital LLC’s holdings in Walgreens Boots Alliance were worth $43,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Walgreens Boots Alliance by 14.5% during the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after buying an additional 10,962,030 shares during the last quarter. Moneta Group Investment Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 84,503.5% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock valued at $311,053,000 after purchasing an additional 8,315,989 shares in the last quarter. BlackRock Inc. grew its position in shares of Walgreens Boots Alliance by 5.6% in the second quarter. BlackRock Inc. now owns 66,949,919 shares of the pharmacy operator’s stock valued at $1,907,403,000 after purchasing an additional 3,543,790 shares during the last quarter. Invesco Ltd. increased its stake in shares of Walgreens Boots Alliance by 21.5% during the 3rd quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after purchasing an additional 3,013,807 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Walgreens Boots Alliance by 15.8% during the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after purchasing an additional 1,720,228 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $21.69 on Friday. Walgreens Boots Alliance, Inc. has a 12 month low of $19.68 and a 12 month high of $36.58. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.30 and a current ratio of 0.66. The business has a 50-day moving average of $21.71 and a two-hundred day moving average of $22.27.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same quarter last year, the firm posted $1.16 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.25 earnings per share for the current fiscal year.

Walgreens Boots Alliance Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a yield of 4.61%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.29%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. HSBC reissued a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Barclays started coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 target price on the stock. SVB Leerink cut their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research report on Monday, March 18th. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $22.00 to $21.00 and set an “underweight” rating on the stock in a research report on Tuesday, March 26th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $25.00.

View Our Latest Report on Walgreens Boots Alliance

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 15,209 shares of the business’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total transaction of $350,567.45. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Timothy C. Wentworth purchased 10,000 shares of the stock in a transaction that occurred on Friday, January 5th. The stock was acquired at an average cost of $24.22 per share, with a total value of $242,200.00. Following the acquisition, the chief executive officer now owns 585,122 shares in the company, valued at $14,171,654.84. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Nancy M. Schlichting sold 15,209 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total transaction of $350,567.45. The disclosure for this sale can be found here. 17.40% of the stock is owned by insiders.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.